Do we need to rethink the diagnoses melanoma <i>in situ</i> and severely dysplastic naevus?-Reference-Cited by-同舟云学术

Do we need to rethink the diagnoses melanoma in situ and severely dysplastic naevus?

Published:2022-04-07 Issue:6 Volume:186 Page:1030-1032
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Semsarian Caitlin R.¹^ORCID,Ma Tara¹,Nickel Brooke¹,Scolyer Richard A.²³⁴^ORCID,Ferguson Peter M.²³⁴,Soyer H. Peter⁵⁶,Parker Lisa⁷⁸,Barratt Alexandra¹,Thompson John F.²³⁹^ORCID,Bell Katy J.L.¹^ORCID

Affiliation:

1. Sydney School of Public Health, Faculty of Medicine and Health The University of Sydney Sydney NSW Australia

2. Melanoma Institute Australia The University of Sydney Sydney NSW Australia

3. Faculty of Medicine and Health The University of Sydney Sydney NSW Australia

4. Tissue Pathology and Diagnostic Oncology Royal Prince Alfred Hospital & NSW Health Pathology Camperdown NSW Australia

5. The University of Queensland Diamantina Institute The University of Queensland, Dermatology Research Centre QLD Woolloongabba Australia

6. Dermatology Department Princess Alexandra Hospital QLD Woolloongabba Australia

7. Sydney School of Pharmacy, Charles Perkins Centre, Faculty of Medicine and Health The University of Sydney Sydney NSW Australia

8. Department of Radiation Oncology Royal North Shore Hospital Sydney NSW Australia

9. Department of Melanoma and Surgical Oncology Royal Prince Alfred Hospital Camperdown NSW Australia

Funder

National Health and Medical Research Council

Publisher

Oxford University Press (OUP)

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.21010

Reference8 articles.

1. Estimating the magnitude of cancer overdiagnosis in Australia

2. The Rapid Rise in Cutaneous Melanoma Diagnoses

3. Fear of new or recurrent melanoma after treatment for localised melanoma

4. Should we rename low risk cancers?

5. Renaming low risk conditions labelled as cancer

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melanoma in situ and low risk pT1a melanoma: Need for new diagnostic terminology;Clinics in Dermatology;2024-09

2. Estimating the magnitude and healthcare costs of melanoma in situ and thin invasive melanoma overdiagnosis in Australia;British Journal of Dermatology;2024-07-19

3. A clinical impact study of dermatologists' use of diagnostic gene expression profile testing to guide patient management;Melanoma Management;2024-04-18

4. The effects of the COVID-19 pandemic on the diagnosis and prognosis of melanoma 2 years after the pandemic in two Romanian counties;Frontiers in Medicine;2024-01-23

5. Ecological study estimating melanoma overdiagnosis in the USA using the lifetime risk method;BMJ Evidence-Based Medicine;2024-01-19